Lapatinib Recruiting Phase 1 Trials for BRAF V600E Mutation Present / Metastatic Thyroid Gland Carcinoma / Recurrent Thyroid Gland Carcinoma / Metastatic Malignant Neoplasm in the Thyroid Gland / BRAF V600K Mutation Present / Unresectable Thyroid Gland Carcinoma Treatment